Severe hepatic or renal impairment
Lipid Panel Frequency The ACC/AHA 2019 guideline on the management of blood cholesterol recommends a fasting lipid panel 4 to 12 weeks after starting a PCSK9 inhibitor, then every 3 to 12 months thereafter to confirm therapeutic response
Wink S, Hiemstra S, Herpers B, van de Water B
Tirzepatide Maintenance Dose After Weight Loss The recommended tirzepatide doses for maintenance of weight loss are 5 mg, 10 mg, or 15 mg weekly, depending on a persons response
Weeks 8 to 12: The Full Clinical Picture Skin texture, hair quality, and cognitive function show their most pronounced changes in this window
Ask about specific protocols during your consultation